Genome-scale analysis of lung cancer progression

American Journal of PharmacoGenomics

Volumn 4, Issue 3, 2004, Pages 169-176

  Malyankar, Uriel M ^a   MacDougall, John R ^a  

^a CURAGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; GEMCITABINE; IRINOTECAN; MESSENGER RNA; NAVELBINE; PACLITAXEL; PLATINUM DERIVATIVE; TRASTUZUMAB;

ADVANCED CANCER; ANIMAL MODEL; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG CANCER; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; REVIEW; SMOKING CESSATION; UNITED STATES;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; GENOME; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

ANIMALIA;

EID: 3042787899     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200404030-00004     Document Type: Review

References (41)

1. American Cancer Society. Cancer facts and figures 2003 [online]. Available from URL: http://www.cancer.org/docroot/STT/stt_0_2003.asp?sitearea= ST-T&level=1/ [Accessed 2004 May 2]
2. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003; 95 (17): 1276-99
3. International histologic classification of tumours: no. 1. In: Kreyberg L, Liebow AA, Uehlinger EA. Histologic typing of lung tumours. 2nd ed. Geneva: World Health Organization, 1981
4. National Cancer Institute. Non-small cell lung cancer (PDQ®): treatment [online]. Available from URL: http://www.cancer.gov/cancerinfo/pdq/ treatment/non-small-cell-lung/healthprofessional/ [Accessed 2004 May 2]
5. Collins FS, Morgan M, Patrinos A. The human genome project: lessons from large-scale biology. Science 2003; 300 (5617): 286-90
6. Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95 (25): 14863-8
7. Schulze A, Downward J. Navigating gene expression using microarrays: a technology review. Nat Cell Biol 2001; 3 (8): E190-5
8. Butte A. The use and analysis of microarray data. Nat Rev Drug Discov 2002; 1 (12): 951-60
9. Kaminski N, Friedman N. Practical approaches to analyzing results of microarray experiments. Am J Respir Cell Mol Biol 2002; 27 (2): 125-32
10. Bauer D, Muller H, Reich J, et al. Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR). Nucleic Acids Res 1993; 21 (18): 4272-80
11. Velculescu VE, Zhang L, Vogelstein B, et al. Serial analysis of gene expression. Science 1995; 270 (5235): 484-7
12. Shimkets RA, Lowe DG, Tai JT, et al. Gene expression analysis by transcript profiling coupled to a gene database query. Nat Biotechnol 1999; 17 (8): 798-803
13. Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993; 259 (5097): 946-51
14. Petersen S, Heckert C, Rudolf J, et al. Gene expression profiling of advanced lung cancer. Int J Cancer 2000; 86 (4): 512-7
15. Wang T, Hopkins D, Schmidt C, et al. Identification of genes differentially overexpressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis. Oncogene 2000; 19 (12): 1519-28
16. Giordano TJ, Shedden KA, Schwartz DR, et al. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 2001; 159 (4): 1231-8
17. Chen JJ, Peck K, Hong TM, et al. Global analysis of gene expression in invasion by a lung cancer model. Cancer Res 2001; 61 (13): 5223-30
18. Schuler GD. Pieces of the puzzle: expressed sequence tags and the catalog of human genes. J Mol Med 1997; 75 (10): 694-8
19. Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 2001; 98 (24): 13784-9
20. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 2001; 98 (24): 13790-5
21. Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002; 8 (8): 816-24
22. Wigle DA, Jurisica I, Radulovich N, et al. Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res 2002; 62 (11): 3005-8
23. Miura K, Bowman ED, Simon R, et al. Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. Cancer Res 2002; 62 (11): 3244-50
24. Balsara BR, Testa JR. Chromosomal imbalances in human lung cancer. Oncogene 2002; 21 (45): 6877-83
25. Steinert R, von Hoegen P, Fels LM, et al. Proteomic prediction of disease outcome in cancer: clinical framework and current status. Am J Pharmacogenomics 2003; 3 (2): 107-15
26. Chen G, Gharib TG, Huang CC, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002; 1 (4): 304-13
27. Campa MJ, Wang MZ, Howard B, et al. Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res 2003; 63 (7): 1652-6
28. National Human Genome Research Institute. NHGRI tissue microarray project [online]. Available from URL: http://www.research.nhgri.nih.gov/tma/ [Accessed 2004 May 2]
29. Volm M, Koomagi R, Mattern J, et al. Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients. Clin Cancer Res 2002; 8 (6): 1843-8
30. Bretones RM, Veve R, Gabrielson E, et al. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol 2002; 20 (10): 2417-28
31. Virtanen C, Ishikawa Y, Honjoh D, et al. Integrated classification of lung tumors and cell lines by expression profiling. Proc Natl Acad Sci U S A 2002; 99 (19): 12357-62
32. Pedersen N, Mortensen S, Sorensen SB, et al. Transcriptional gene expression profiling of small cell lung cancer cells. Cancer Res 2003; 63 (8): 1943-53
33. Kakiuchi S, Daigo Y, Tsunoda T, et al. Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol Cancer Res 2003; 1 (7): 485-99
34. Staunton JE, Slonim DK, Coller HA, et al. Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci U S A 2001; 98 (19): 10787-92
35. Developmental Therapeutics Program NCI/NIH. DTP human tumor cell line screen [online]. Available from URL: http://dtp.nci.nih.gov/branches/btb/ivclsp. html [Accessed 2004 Apr 23]
36. Kikuchi T, Daigo Y, Katagiri T, et al. Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene 2003; 22 (14): 2192-205
37. Zembutsu H, Ohnishi Y, Daigo Y, et al. Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839. Int J Oncol 2003; 23 (1): 29-39
38. Borczuk AC, Gorenstein L, Walter KL, et al. Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol 2003 Nov; 163 (5): 1949-60
39. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004 Apr 29 [Epub ahead of print]
40. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001; 29 (4): 365-71
41. Minimum information about a microarray experiment - MIAME [online]. Available from URL: http://www.mged.org/Workgroups/MIAME/miame.html [Accessed 2004 May 2]